Cart
sales@molnova.com
SU3327
CAS No. 40045-50-9
SU3327( —— )
Catalog No. M24361 CAS No. 40045-50-9
SU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 85 | In Stock |
|
| 2MG | 30 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 174 | In Stock |
|
| 50MG | 305 | In Stock |
|
| 100MG | 462 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU3327
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
-
DescriptionSU3327 is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).
-
In Vitro——
-
In VivoAnimal Model:Male BKS.Cg-+Leprdb/+Leprdb/OlaHsd db/db mice (11-week-old ) injected with insulin Dosage:25 mg/kg Administration:Intraperitoneal injection Result:Resulted in a statistically significant reduction in blood glucose levels.
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetJNK
-
RecptorJNK|JNK-JIP interactions
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number40045-50-9
-
Formula Weight261.3
-
Molecular FormulaC5H3N5O2S3
-
Purity>98% (HPLC)
-
SolubilityDMSO:62.5 mg/mL (239.19 mM; Need ultrasonic)
-
SMILESNc1nnc(Sc2ncc([N+]([O-])=O)s2)s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.De SK, et al. Design, synthesis, and structure-activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase. J Med Chem. 2009 Apr 9;52(7):1943-52.
molnova catalog
related products
-
Tanzisertib
Tanzisertib (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.Tanzisertib (CC-930) inhibits the formation of phospho-cJun in human PBMC stimulated by phorbol-12-myristate-13-acetate and phytohemeagglutinin (IC50=1 μM)[1] and it blocks the JNK pathway that is activated by pro-fibrotic cytokines in systemic sclerosis.
-
IQ3
IQ3 is a selective inhibitor of JNK3(JNK3, JNK1 and JNK2 with Kd of 66 nM, 240 nM and 290 nM, respectively).
-
JNK Inhibitor VIII
JNK Inhibitor VIII is an ATP-competitive selective inhibitor of c-Jun N-terminal kinase (JNK)(IC50 values of 45 nM and 160 nM for JNK-1 and -2, respectively).
